<p>MicroRNAs with more than 1.5-fold change in HER2-positive cells but not in HER2-negative cells.</p>*<p>: RFC, relative fold change = (Fold change of miR) – (average fold change of the miR in MCF7 and MBA-MD-231).</p
<p>Using ceRNA1 transcription rate as control parameter we evaluate the fold change in the number o...
1<p>necrotic cell lysates <sup>2</sup>RQ is fold change in expression calculated from 2<sup>−δδCt</s...
*<p>miRNAs with Nanostring counts that passed the minimum intensity filter and have fold changes rel...
<p>2A: A heat map and clustergram of the expression profile of 71 pre-filtered microRNAs. The red an...
(a) HER2+ and ER+ BT-474 cells were treated with both tamoxifen and trastuzumab while ER+ MCF-7 cell...
Trastuzumab has been used for the treatment of HER2-positive breast cancer (BC). However, a subset o...
a<p>Status is determined according to Median Fold Change; <sup>b</sup> Number of GBMs showing the mo...
<p>Comparison of the fold changes of three miRNAs found deregulated in different comparisons in the ...
<p>Forty-two miRs deregulated in tumoral compared to matched normal tissue and selected by p<0.001. ...
<p>Comparison of miRNA expression fold changes between microarray and RT-qPCR.</p
<p>Results represent fold change. “-” represents no significant change between vehicle treated MCF-7...
<p>Thirty-four miRs deregulated in tumoral compared to matched normal tissue and selected by p<0.01....
<p>Colony formation of each indicated cell line calculated using a ColCount Colony Counter with supp...
MicroRNAs (miRNAs) are implicated in numerous physiologic and pathologic processes, such as the deve...
<p>Blue bars indicate 3h vs 0h fold change and red bars indicate 12h vs 0h fold change. (A) miRNA ex...
<p>Using ceRNA1 transcription rate as control parameter we evaluate the fold change in the number o...
1<p>necrotic cell lysates <sup>2</sup>RQ is fold change in expression calculated from 2<sup>−δδCt</s...
*<p>miRNAs with Nanostring counts that passed the minimum intensity filter and have fold changes rel...
<p>2A: A heat map and clustergram of the expression profile of 71 pre-filtered microRNAs. The red an...
(a) HER2+ and ER+ BT-474 cells were treated with both tamoxifen and trastuzumab while ER+ MCF-7 cell...
Trastuzumab has been used for the treatment of HER2-positive breast cancer (BC). However, a subset o...
a<p>Status is determined according to Median Fold Change; <sup>b</sup> Number of GBMs showing the mo...
<p>Comparison of the fold changes of three miRNAs found deregulated in different comparisons in the ...
<p>Forty-two miRs deregulated in tumoral compared to matched normal tissue and selected by p<0.001. ...
<p>Comparison of miRNA expression fold changes between microarray and RT-qPCR.</p
<p>Results represent fold change. “-” represents no significant change between vehicle treated MCF-7...
<p>Thirty-four miRs deregulated in tumoral compared to matched normal tissue and selected by p<0.01....
<p>Colony formation of each indicated cell line calculated using a ColCount Colony Counter with supp...
MicroRNAs (miRNAs) are implicated in numerous physiologic and pathologic processes, such as the deve...
<p>Blue bars indicate 3h vs 0h fold change and red bars indicate 12h vs 0h fold change. (A) miRNA ex...
<p>Using ceRNA1 transcription rate as control parameter we evaluate the fold change in the number o...
1<p>necrotic cell lysates <sup>2</sup>RQ is fold change in expression calculated from 2<sup>−δδCt</s...
*<p>miRNAs with Nanostring counts that passed the minimum intensity filter and have fold changes rel...
DOI
Add to ORKG